Liu X - Search Results

1

Expression of miR-29c, miR-93, and miR-429 as potential biomarkers for detection of early stage non-small lung cancer.

Zhu W, He J, Chen D, Zhang B, Xu L, Ma H, Liu X, Zhang Y, Le H. Zhu W, et al. Among authors: liu x. PLoS One. 2014 Feb 11;9(2):e87780. doi: 10.1371/journal.pone.0087780. eCollection 2014. PLoS One. 2014. PMID: 24523873 Free PMC article.

2

High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer.

Liu XG, Zhu WY, Huang YY, Ma LN, Zhou SQ, Wang YK, Zeng F, Zhou JH, Zhang YK. Liu XG, et al. Med Oncol. 2012 Jun;29(2):618-26. doi: 10.1007/s12032-011-9923-y. Epub 2011 Apr 24. Med Oncol. 2012. PMID: 21516486

3

Prognostic evaluation of CapG, gelsolin, P-gp, GSTP1, and Topo-II proteins in non-small cell lung cancer.

Zhu WY, Hunag YY, Liu XG, He JY, Chen DD, Zeng F, Zhou JH, Zhang YK. Zhu WY, et al. Anat Rec (Hoboken). 2012 Feb;295(2):208-14. doi: 10.1002/ar.21523. Epub 2011 Dec 21. Anat Rec (Hoboken). 2012. PMID: 22190510 Free article.

4

[Expression and prognostic value of vacuole membrane protein 1 in non-small-cell lung cancer].

Zhou SQ, Zhou JH, Deng T, Zeng F, Wang YK, Liu XG. Zhou SQ, et al. Zhonghua Yi Xue Za Zhi. 2011 Nov 1;91(40):2828-31. Zhonghua Yi Xue Za Zhi. 2011. PMID: 22333543 Chinese.

5

miRNAs expression profiling to distinguish lung squamous-cell carcinoma from adenocarcinoma subtypes.

Zhang YK, Zhu WY, He JY, Chen DD, Huang YY, Le HB, Liu XG. Zhang YK, et al. J Cancer Res Clin Oncol. 2012 Oct;138(10):1641-50. doi: 10.1007/s00432-012-1240-0. Epub 2012 May 22. J Cancer Res Clin Oncol. 2012. PMID: 22618509

6

Evaluation of dynamic change of serum miR-21 and miR-24 in pre- and post-operative lung carcinoma patients.

Le HB, Zhu WY, Chen DD, He JY, Huang YY, Liu XG, Zhang YK. Le HB, et al. Med Oncol. 2012 Dec;29(5):3190-7. doi: 10.1007/s12032-012-0303-z. Epub 2012 Jul 11. Med Oncol. 2012. PMID: 22782668

7

Anticancer effects of cinnamic acid in lung adenocarcinoma cell line h1299-derived stem-like cells.

Huang Y, Zeng F, Xu L, Zhou J, Liu X, Le H. Huang Y, et al. Among authors: liu x. Oncol Res. 2013;20(11):499-507. doi: 10.3727/096504013X13685487925095. Oncol Res. 2013. PMID: 24063280

8

Downregulation of miR-21 increases cisplatin sensitivity of non-small-cell lung cancer.

Xu L, Huang Y, Chen D, He J, Zhu W, Zhang Y, Liu X. Xu L, et al. Among authors: liu x. Cancer Genet. 2014 May;207(5):214-20. doi: 10.1016/j.cancergen.2014.04.003. Epub 2014 Apr 13. Cancer Genet. 2014. PMID: 24906642

9

Differential expression of miR-125a-5p and let-7e predicts the progression and prognosis of non-small cell lung cancer.

Zhu WY, Luo B, An JY, He JY, Chen DD, Xu LY, Huang YY, Liu XG, Le HB, Zhang YK. Zhu WY, et al. Cancer Invest. 2014 Oct;32(8):394-401. doi: 10.3109/07357907.2014.922569. Epub 2014 Jun 19. Cancer Invest. 2014. PMID: 24945821

10

Increased expression of T cell immunoglobulin and mucin domain 4 is positively associated with the disease severity of patients with ankylosing spondylitis.

Chen D, He J, Lu C, Zhou J, Fang K, Liu X, Xu L. Chen D, et al. Among authors: liu x. Inflammation. 2015;38(3):935-40. doi: 10.1007/s10753-014-0055-3. Inflammation. 2015. PMID: 25359708

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

137,858 results

Search Page

Filters